Russell Investments Group
ARQT icon

Russell Investments Group’s Arcutis Biotherapeutics ARQT Stock Holding History

Russell Investments Group’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.47M Sell
62,245
-15,812
-20% -$404K ﹤0.01% 2033
2025
Q4 		$2.27M Buy
78,057
+55,961
+253% +$1.43M ﹤0.01% 1804
2025
Q3 		$417K Buy
22,096
+10,906
+97% +$172K ﹤0.01% 2548
2025
Q2 		$157K Buy
11,190
+10,950
+4,563% +$154K ﹤0.01% 2708
2025
Q1 		$3.75K Hold
240
– – ﹤0.01% 3408
2024
Q4 		$3.34K Sell
240
-9,144
-97% -$100K ﹤0.01% 3358
2024
Q3 		$87.3K Buy
9,384
+8,381
+836% +$82.7K ﹤0.01% 2686
2024
Q2 		$9.33K Buy
1,003
+982
+4,676% +$8.88K ﹤0.01% 3091
2024
Q1 		$208 Buy
+21
New +$157 ﹤0.01% 3276
2023
Q1 		– Sell
-15,972
Closed -$236K – 3293
2022
Q4 		$236K Buy
15,972
+2,774
+21% +$48.5K ﹤0.01% 2529
2022
Q3 		$251K Buy
+13,198
New +$299K ﹤0.01% 2487
2021
Q1 		– Sell
-1,200
Closed -$33K – 3097
2020
Q4 		$33K Sell
1,200
-400
-25% -$9.8K ﹤0.01% 2951
2020
Q3 		$46K Buy
+1,600
New +$42.7K ﹤0.01% 3081

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return